HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC)

被引:41
作者
Vidal, N
Mulanga, C
Bazepeo, SE
Mwamba, JK
Tshimpaka, J
Kashi, M
Mama, N
Valéa, D
Delaporte, E
Lepira, F
Peeters, M [1 ]
机构
[1] IRD, Retrovirus Lab, UMR145, BP 64501, F-34394 Montpellier 1, France
[2] Lab PNLS, Kinshasa, DEM REP CONGO
[3] Lab PNLS, Lubumbashi, DEM REP CONGO
[4] Lab PNLS, Kisangani, DEM REP CONGO
[5] Lab Hop Dipumba, Mbuyi Mayi, DEM REP CONGO
关键词
D O I
10.1089/aid.2006.22.202
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
To study recombination and the natural polymorphism in pol of HIV-1 strains in the Democratic Republic of Congo (DRC) we sequenced the protease and RT genes for 70 HIV-1 strains previously characterized in the env V3-V5 region from a sentinel surveillance study in 2002. For 41 of the 70 (58.6%) strains, the same subtype/CRF designations were observed in pol and env. Twenty-three (32.9%) of 70 pol sequences were complex recombinants involving two to five subtypes as well as fragments that could not be classified into any of the known subtypes. All subtypes were involved in recombination events. Unclassified (U) and env subtype H strains were very likely to be recombinant strains. Overall, many minor mutations were identified in the protease sequences. Although at the time of our study ARV use was not yet widespread in DRC, three strains were identified with one major mutation associated with drug resistance: L90M and M46L in protease and K103N in RT.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 17 条
[1]
Abecasis A., 2005, Infection Genetics and Evolution, V5, P231, DOI 10.1016/j.meegid.2004.07.007
[2]
Human immunodeficiency virus type 1 group M protease in Cameroon: Genetic diversity and protease inhibitor mutational features [J].
Fonjungo, PN ;
Mpoudi, EN ;
Torimiro, JN ;
Alemnji, GA ;
Eno, LT ;
Lyonga, EJ ;
Nkengasong, JN ;
Lal, RB ;
Rayfield, M ;
Kalish, ML ;
Folks, TM ;
Pieniazek, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :837-845
[3]
Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate [J].
Harris, ME ;
Serwadda, D ;
Sewankambo, N ;
Kim, B ;
Kigozi, G ;
Kiwanuka, N ;
Phillips, JB ;
Wabwire, F ;
Meehen, M ;
Lutalo, T ;
Lane, JR ;
Merling, R ;
Gray, R ;
Wawer, M ;
Birx, DL ;
Robb, ML ;
McCutchan, FE .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (17) :1281-1290
[4]
Kalish ML, 2004, EMERG INFECT DIS, V10, P1227
[5]
Genetic diversity of HIV type 1 in Likasi, southeast of the Democratic Republic of Congo [J].
Kita, K ;
Ndembi, N ;
Ekwalanga, M ;
Ido, E ;
Kazadi, R ;
Bikandou, B ;
Takehisa, J ;
Takemura, T ;
Kageyama, S ;
Tanaka, J ;
Parra, HJ ;
Hayami, M ;
Ichimura, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (12) :1352-1357
[6]
Distinct human immunodeficiency virus type 1 subtype a virus circulating in West Africa:: Sub-subtype A3 [J].
Meloni, ST ;
Kim, B ;
Sankalé, JL ;
Hamel, DJ ;
Tovanabutra, S ;
Mboup, S ;
McCutchan, FE ;
Kanki, PJ .
JOURNAL OF VIROLOGY, 2004, 78 (22) :12438-12445
[7]
Identification of a novel clade of human immunodeficiency virus type 1 in Democratic Republic of Congo [J].
Mokili, JLK ;
Rogers, M ;
Carr, JK ;
Simmonds, P ;
Bopopi, JM ;
Foley, BT ;
Korber, BT ;
Birx, DL ;
McCutchan, FE .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (11) :817-823
[8]
Peeters M, 2000, AIDS, V14, pS129
[9]
Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials [J].
Peeters, M ;
Toure-Kane, C ;
Nkengasong, JN .
AIDS, 2003, 17 (18) :2547-2560
[10]
Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide [J].
Pieniazek, D ;
Rayfield, M ;
Hu, DJ ;
Nkengasong, J ;
Wiktor, SZ ;
Downing, R ;
Biryahwaho, B ;
Mastro, T ;
Tanuri, A ;
Soriano, V ;
Lal, R ;
Dondero, T .
AIDS, 2000, 14 (11) :1489-1495